Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6373 studies found for:    "HIV Infections"
Show Display Options
Rank Status Study
21 Completed A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.
Condition: HIV Infections
Intervention: Drug: Nystatin
22 Not yet recruiting Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol Use
Condition: HIV Infection
Interventions: Other: ART initiation at time of HIV diagnosis;   Other: ART at 24 weeks post-diagnosis
23 Unknown  Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults
Condition: HIV Infection
Interventions: Biological: ALVAC-HIV;   Biological: AIDSVAX B/E;   Biological: Placebo for ALVAC-HIV;   Biological: Placebo for AIDSVAX B/E;   Biological: Hepatitis B vaccine;   Biological: Tetanus toxoid vaccine;   Biological: Placebo for hepatitis B vaccine;   Biological: Placebo for tetanus vaccine
24 Terminated Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance
Condition: HIV Infections
Interventions: Drug: Indinavir;   Drug: Lamivudine;   Drug: Ritonavir
25 Suspended On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men
Condition: HIV Infection
Interventions: Drug: Truvada;   Drug: Placebo
26 Unknown  Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection
Condition: HIV Infections
Interventions: Drug: Truvada (tenofovir/emitricitabine);   Drug: Kaletra (lopinavir/ritonavir)
27 Completed Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)
Condition: HIV Infection
Interventions: Drug: Tenofovir, emtricitabine, maraviroc;   Drug: Tenofovir, emtricitabine, lopinavir/r
28 Completed Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)
Condition: HIV Infection
Interventions: Drug: Tenofovir, Emtricitabine, Lopinavir/r;   Drug: Tenofovir, Emtricitabine, Raltegravir
29 Completed A Pilot Study of Allogeneic Lymphocyte Transfer in HIV Infection
Condition: HIV Infections
Intervention: Procedure: Allogeneic lymphocyte transfer
30 Completed Effects of Creatine and Resistance Exercise Training in People With HIV Infection
Condition: HIV Infections
Interventions: Procedure: Use of creatine monohydrate (a dietary supplement);   Behavioral: Progressive resistance exercise training
31 Completed Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)
Condition: HIV Infections
Intervention: Drug: Interleukin-2
32 Terminated Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression
Condition: HIV Infections
Interventions: Drug: Interferon alfa-2b;   Procedure: Structured treatment interruptions
33 Completed A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Lamivudine/Zidovudine;   Drug: Ritonavir;   Drug: Hydroxyurea;   Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Nelfinavir mesylate;   Drug: Efavirenz;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine;   Drug: Didanosine
34 Completed A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection
Condition: HIV Infections
Intervention: Drug: Levofloxacin
35 Completed HIV Disclosure and Medication Adherence, a Pilot Study
Condition: HIV Infection
Intervention:
36 Completed An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score > 40 Percent and < 100 Percent
Condition: HIV Infections
Intervention: Drug: Pentoxifylline
37 Completed A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection
Condition: HIV Infections
Intervention: Drug: Zidovudine
38 Completed Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241)
Condition: HIV Infections
Intervention: Drug: Vicriviroc
39 Completed CDC HIV Testing Guidelines: Unresolved Ethical Concerns
Condition: HIV Infections
Intervention: Other: CDC HIV testing recommendations
40 Enrolling by invitation Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women
Condition: HIV Infections
Intervention: Drug: Placebo Vaginal Ring

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.